Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Capital Leases (2018)

Regenxbio (RGNX) has 1 years of Capital Leases data on record, last reported at $5.9 million in Q4 2018.

  • For Q4 2018, Capital Leases changed N/A year-over-year to $5.9 million; the TTM value through Dec 2018 reached $5.9 million, changed N/A, while the annual FY2018 figure was $5.9 million, N/A changed from the prior year.
  • Capital Leases reached $5.9 million in Q4 2018 per RGNX's latest filing.
  • Across five years, Capital Leases topped out at $5.9 million in Q4 2018 and bottomed at $5.9 million in Q4 2018.